PLXP Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (12 apr 2023 @ 22:00):

Stats
Dagens volum	50.38M
Gjennomsnittsvolum	4.86M
Markedsverdi	2.53M
EPS	$0 ( 2023-11-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.223
ATR14	$0.0270 (469.57%)

Insider Trading

Date	Person	Action	Amount	type
2022-03-15	Giordano Natasha	Buy	4 100	Common Stock
2022-03-15	O'connor Rita M	Buy	3 700	Common Stock
2022-03-15	O'connor Rita M	Buy	10 000	Common Stock
2022-02-22	Valentino Michael J	Buy	80 000	Stock Option (right to buy)
2022-02-22	O'connor Rita M	Buy	110 000	Stock Option (right to buy)

INSIDER POWER
0.00
Last 94 transactions
Buy: 5 718 001 \| Sell: 1 856 163

Volum Korrelasjon

Lang: 0.18 (neutral)

Kort: -0.79 (moderate negative)

Signal:(38.252) Neutral

PLx Pharma Inc Korrelasjon

10 Mest positive korrelasjoner
ONCS	0.955
WISA	0.952
INSG	0.947
IMRX	0.943
PRTK	0.943
INVE	0.943
TOI	0.942
VERV	0.938
TIL	0.937
TFFP	0.935

10 Mest negative korrelasjoner
AGFS	-0.912
CCRC	-0.91
LRFC	-0.907
MNKD	-0.903
IBEX	-0.901
STAY	-0.896
LWAC	-0.894
NWFL	-0.892
HZNP	-0.889
SLGN	-0.887

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

PLx Pharma Inc Korrelasjon - Valuta/Råvare

0.64
( weak )

0.79
( moderate )

0.00
( neutral )

0.78
( moderate )

-0.13
( neutral )

-0.79
( moderate negative )

PLx Pharma Inc Økonomi

Annual	2021
Omsetning:	$8.21M
Bruttogevinst:	$3.40M (41.46 %)
EPS:	$-1.714

FY	2021
Omsetning:	$8.21M
Bruttogevinst:	$3.40M (41.46 %)
EPS:	$-1.714

FY	2020
Omsetning:	$30 430.00
Bruttogevinst:	$30.43 (0.10 %)
EPS:	$-1.740

FY	2019
Omsetning:	$565 464
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-2.30

Financial Reports:

No articles found.

PLx Pharma Inc

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.